Medicine Science (Jun 2020)

Serum elabela levels in women with tubal ectopic pregnancy: A case-control study

  • Evrim Gul,
  • Rulin Deniz,
  • Ebru Celik Kavak,
  • Cengiz Sanli,
  • Ibrahim Batmaz,
  • Gulay Bulu,
  • Salih Burcin Kavak,
  • Yakup Baykus

DOI
https://doi.org/10.5455/medscience.2019.08.9185
Journal volume & issue
Vol. 9, no. 2
pp. 289 – 92

Abstract

Read online

Elabela, a circulating peptide hormone derived from the placenta, plays a crucial role in embryonic development and function of the human placenta during pregnancy. We aimed to investigate serum elabela levels in ectopic pregnancy. Sixty cases admitted to Emergency Department and Obstetrics and Gynecology Clinic were included in this case-control study. Thirty women with tubal ectopic pregnancy constituted Group 1 and 30 women with healthy pregnancy served as controls (Group 2). Blood samples were collected from all participants. Demographic and obstetric characteristics of the whole study cohort were also recorded. Levels of serum elabela were measured in each group by enzyme-linked immunosorbent assay . Age, gender, gestational age, obstetrics history, and body mass index of the groups were similar. Mean serum elabela levels were 7.52 ± 1.1 ng/mL and 7.05 ± 1.2 ng/mL in group 1 and group 2, respectively. There was no statistically significant difference between the two groups with respect to serum elabela levels ‎ (t=1.581, p=0.119). In the present study, serum elabela levels were not significantly different in women with ectopic pregnancies than healthy pregnancies. Since placenta is the primary source of elabela, this lack of difference might be due to the insufficient placental as well as fetal development in fallopian tubes. [Med-Science 2020; 9(2.000): 289-92]

Keywords